These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7700503)
1. Antagonism of type II, but not type I glucocorticoid receptors results in elevated basal luteinizing hormone release in male rats. Briski KP; Sylvester PW Neuroendocrinology; 1994 Dec; 60(6):601-8. PubMed ID: 7700503 [TBL] [Abstract][Full Text] [Related]
2. Effects of peripheral versus central administration of the endogenous glucocorticoid, corticosterone, and the glucocorticoid receptor agonist, RU 28362, on LH release in male rats. Briski KP Brain Res; 1995 Jan; 670(1):66-74. PubMed ID: 7719726 [TBL] [Abstract][Full Text] [Related]
3. The antiglucocorticoid, RU486, attenuates stress-induced decreases in plasma-luteinizing hormone concentrations in male rats. Briski KP; Vogel KL; McIntyre AR Neuroendocrinology; 1995 Jun; 61(6):638-45. PubMed ID: 7659189 [TBL] [Abstract][Full Text] [Related]
4. Stimulatory vs. inhibitory effects of acute stress on plasma LH: differential effects of pretreatment with dexamethasone or the steroid receptor antagonist, RU 486. Briski KP Pharmacol Biochem Behav; 1996 Sep; 55(1):19-26. PubMed ID: 8870033 [TBL] [Abstract][Full Text] [Related]
5. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat. Briski KP; Vogel KL Neuropeptides; 1995 Mar; 28(3):175-81. PubMed ID: 7791961 [TBL] [Abstract][Full Text] [Related]
6. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Ratka A; Sutanto W; Bloemers M; de Kloet ER Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833 [TBL] [Abstract][Full Text] [Related]
7. Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism. Li M; Wen C; Fraser T; Whitworth JA J Hypertens; 1999 Mar; 17(3):419-26. PubMed ID: 10100081 [TBL] [Abstract][Full Text] [Related]
8. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. van den Berg DT; de Kloet ER; van Dijken HH; de Jong W Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978 [TBL] [Abstract][Full Text] [Related]
9. Blockage of glucocorticoid, but not mineralocorticoid receptors prevents the persistent increase in circulating basal corticosterone concentrations following stress in the rat. Moldow RL; Beck KD; Weaver S; Servatius RJ Neurosci Lett; 2005 Feb; 374(1):25-8. PubMed ID: 15631890 [TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats. Leposavic G; Cover PO; Buckingham JC Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint. Calvo N; Volosin M Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340 [TBL] [Abstract][Full Text] [Related]
12. Acute inhibition of pituitary LH release in the male rat by the glucocorticoid agonist decadron phosphate. Briski KP; Sylvester PW Neuroendocrinology; 1991 Oct; 54(4):313-20. PubMed ID: 1758573 [TBL] [Abstract][Full Text] [Related]
13. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. van Haarst AD; Oitzl MS; de Kloet ER Neurochem Res; 1997 Nov; 22(11):1323-8. PubMed ID: 9355104 [TBL] [Abstract][Full Text] [Related]
14. Biphasic effects of adrenal steroids on learned helplessness behavior induced by inescapable shock. Kademian SM; Bignante AE; Lardone P; McEwen BS; Volosin M Neuropsychopharmacology; 2005 Jan; 30(1):58-66. PubMed ID: 15496941 [TBL] [Abstract][Full Text] [Related]
15. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake. Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331 [TBL] [Abstract][Full Text] [Related]
16. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors. Jain MR; Pu S; Kalra PS; Kalra SP Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of angiotensin II-induced drinking by glucocorticoids is a specific glucocorticoid type II receptor (GR)-mediated event. Sumners C; Gault TR; Fregly MJ Brain Res; 1991 Jun; 552(2):283-90. PubMed ID: 1913190 [TBL] [Abstract][Full Text] [Related]
19. FKBP5 mRNA Expression Is a Biomarker for GR Antagonism. Bali U; Phillips T; Hunt H; Unitt J J Clin Endocrinol Metab; 2016 Nov; 101(11):4305-4312. PubMed ID: 27459525 [TBL] [Abstract][Full Text] [Related]
20. In contrast to glucocorticoid receptors, mineralocorticoid receptors are not autoregulated in rat distal colon epithelia. Meyer AS; Schmidt TJ Endocrinology; 1994 Mar; 134(3):1163-72. PubMed ID: 8119155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]